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OVERCOMING THE LEARNING CURVE OF A RETZIUS-SPARING APPROACH FOR ROBOT-
ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY: ONCOLOGICAL AND FUNCTIONAL 
RESULTS ON THE FIRST 200 PATIENTS 
 
A. GALFANO*, F. SOZZI, D. DI TRAPANI, G. PETRALIA, E. STRADA, A.M. BOCCIARDI 
 
Struttura Complessa di Urologia, Ospedale Niguarda Ca' Granda, Milano, Italia 
 
Objective: To evaluate the learning curve of an unexperienced robotic surgeon on pelvic lymph node dissection (R-PLND) 
during robot-assisted laparoscopic radical prostatectomy (RALP) 
Methods: Starting from March 2011, we prospectively recorded the pre-, intra, and postoperative data of all patients 
undergoing R-PLND during RALP. The related surgical experience of the PLND surgeon was 40 open PLNDs as first 
surgeon and 100 robotic surgeries as bedside assistant. We divided the series in 3 groups of 33 cases in order to evaluate the 
learning curve.  
Results: The first 99 consecutive R-PLNDs were included. Median surgical time was 90 minutes. Five patients underwent 
transfusions. One of them underwent embolization of a gluteal artery brench. Overall, complications were recorded in 14% of 
patients. Ten patients reported temporary paresthaesias; 5 patients had lymphorrea for more than 7 days; 10 patients needed to 
put a drain for symptomatic lymphocele, in 2 cases concomitant with deep venous thrombosis. Considering the 3 groups, we 
could notice no change in median surgical time (90 minutes versus 85 versus 105 – p=0,23) and in complications (12%  versus 
15% versus 15% p=0,12); on the contrary, the median number of lymph nodes removed significantly increased in the groups 
(16  versus 18 versus 20 nodes– p=0,02). 
Conclusions: We reported the learning curve of a naïve robotic surgeon with limited open surgery experience. We believe 
that at least 60 robotic PLNDs have to be performed to remove an adequate number of nodes in a limited surgical time. 
 
 
 
 
ROBOTIC-ASSISTED LIVER SURGERY: OUR EXPERIENCE AND SURGICAL OUTCOMES 
 
R. CARUSO*, B. IELPO, E. VICENTE, Y. QUIJANO, H. DURAN, E. DIAZ, I. FABRA, C. OLIVA,  
S. OLIVARES, V. FERRI, J.C. PLAZA, C. CORBACHO, B. MORATO, J. RODRIGUEZ 
 
General Surgery, Sanchinarro Hospital, San Pablo CEU University, Madrid, Spagna 
 
Objective: The aim of this study is to present the results of our series of robotic-assisted liver surgery. Robotic-assisted 
technology offers solutions to the fundamental limitations of conventional laparoscopic liver resection. 
Methods: It is a retrospective study of a series of robotic-assisted liver resection from January 2010 to January 2013. 
Outcomes analyzed included: pre-operative data, type of surgery, operative time, estimated blood loss, length of stay, 
complication rate, conversion rate to open, postoperative evolution and follow up. 
Results: It has been included in the study a total of 8 patients: 4 women and 4 men with a mean age of 57 years. Six cases of 
metastases (atypical resections), one hydatis cyst and one cholangiocarcinoma (right hepatectomy). There were no cases of 
conversion to open surgery. Mean operative time was 210 minutes (range: 130-360 minutes) and there were not 
intraoperative complications. The average number of red blood cells transfused was 0.6 (range: 0-3 units). Later ICU stay 
average was 3 days and overall hospital stay of 12 days. This series includes the first case of complete robotic hepatectomy 
performed in Spain. 
Conclusions: The study shows that robot-assisted liver surgery is a feasible and safe tool for the minimally invasive resection 
of hepatic lesions. It has similar results to those obtained by laparoscopic and open surgery described in literature. However, 
further prospective randomized studies are needed to confirm these data. 
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PARENCHYMAL SPARING ROBOTIC LIVER SURGERY 
 
M. SCRICCIOLO*, A. BIANCAFARINA, G. CECCARELLI, M. ANGELINI, R. MALATESTI, E. ANDOLFI,  
G. UGOLINI 
 
U.O. Chirurgia Generale, Ospedale San Donato, Arezzo, Italia, U.O.Chirurgia Generale 
 
Objective: In recent years the concept of metastatic liver disease has dramatically changed. Reports of surgical approach to 
multiple bilobar metastases increased. Laparoscopic treatment of metastatic liver disease was first described twenty years ago 
and its limitations are well known: approach to posterior segments and size lesions over 5 cm as reported in Luisville’s 
Consensus Conference of 2008. Introduction of robotic technology overcame technical difficulties of laparoscopic approach 
for hepatic resections. 
Methods: Video shows parenchymal sparing liver resection for metastatic disease. Intraoperative ultrasonography is 
performed to detect lesions and parenchymal resection is achieved by bipolar forceps and monopolar scissors. 3D-vision, 
endowrist tools and surgical field stability overcame technical limitations of traditional laparoscopic surgery, allowing to 
realize accurate and safe dissections of liver parenchyma. 
Results: Since September 2012 we performed 10 full robotic procedures for liver metastatic disease. Mean age was 74 years. 
Total number of metastases removed was 18 and histological exam revealed negative margins in all cases. Mean operative 
time was 342 minutes (range 250-480 min); mean blood loss were 250 ml (range 100-320 ml); there was no conversions. 
Conclusions: Robot assistance facilitates parenchymal sparing surgery, providing good results in terms of bleeding and 
biliary leakage. 
 
 
 
 
ROBOTIC TOTAL MESORECTAL EXCISION FOR RECTAL CANCER 
 
I. MONSELLATO*, W. PETZ, F. UCCELLI, P.P. BIANCHI 
 
Unità di Chirurgia Mini Invasiva, Istituto Europeo di Oncologia, Milano, Italia 
 
Objective: Robotic approach may increase the precision of rectal dissection and overcome technical difficulties of 
laparoscopy. This study evaluate feasibility and oncologic results of a consecutive series of patients. 
Methods: From July 2008 to December 2012, 75 patients received a robotic total mesorectal excision. 
Results: Patients’ median age was 64 years, median BMI was 24 kg/m2. ASA status was 1 in 14 patients, 2 in 49 patients, 3 
in 12 patients. 48% of the patientsreceived a neoadjuvant treatment. Surgical procedure was an anterior resection in 52 
patients (69%) and an abdomino-perineal resection in 31 (31%). Median surgical time was 240 minutes. Two conversion to 
open surgery were necessaries. Major complications requiring reoperation occurred in 5 patients (6.6%). First bowel 
movements were observed in 2 postoperative day, median hospital stay was 6 days. AJCC stage was 0 in 13 patients, I in 18 
patients, II in 10 patients, III in 27 patients and IV in 7 patients. Distal resection margin was positive in one patient, median 
distal resection margin was 3 cm. Circumferential resection margin was positive in two patients: median number of removed 
lymph nodes per patient was 18 (range 4-49). At a median follow up of 23 months (range 1- 53), overall survival is 89% and 
disease-free survival is 72%. 
Conclusions: Robotic-assisted surgery of the rectum is a feasible technique with good clinical and oncologic results. Further 
studies are necessary to evaluate potential advantages of robotic technique in rectal cancer. 
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